Cargando…
Grading Ductal Carcinoma In Situ (DCIS) of the Breast – What’s Wrong with It?
Ductal carcinoma in situ of the breast is a non-obligate precursor of invasive breast cancer, and at its lower risk end might not need treatment, a hypothesis tested in several currently running randomized clinical trials. This review describes the heterogeneity of grading ductal carcinoma in situ (...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Netherlands
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242244/ https://www.ncbi.nlm.nih.gov/pubmed/31776839 http://dx.doi.org/10.1007/s12253-019-00760-8 |